More news about headache relief.  Yesterday there was a study from Canada about a portable machine that zaps headaches too.  It appears to be a growing demand toward electro therapy in many area of health care today versus taking a pill.  Some are implanted while some are used externally.  As the medical device business continues to grow I’m sure there will be even more research in these areas, along with devices that are implanted as well.  Those still bother me a bit when it comes to the brain, although implanted heart defibrillators are becoming more common these days, so the day of other implanted devices may not be too far down the road and accepted as a routine type of procedure. 

As always though, there is still the battle for reimbursement, what is not tested and approved or perhaps deemed experimental by the insurers.  Nice to have the devices and to create a better quality of life, if they are made available when needed.  BD 

----Medtronic, Inc. (NYSE: MDT: 51.35, +0.27, +0.52%) today announced that data from a multi-center, prospective, randomized, single-blinded, controlled investigational study using its neurostimulation system to stimulate the occipital nerves as a potential approach to treating medically refractory chronic migraines will be presented during a late-breaking session at the annual scientific meeting of the American Headache Society (AHS: 17.25, +0.19, +1.11%) tomorrow in Boston. This study, called Occipital Nerve Stimulation for the Treatment of Intractable Migraine (ONSTIM), included patients who have regularly experienced 15 or more headache days per month that were not responsive to conventional medical therapies.

Medtronic Announces First Clinical Data on Occipital Nerve Stimulation for Chronic Migraine to Be Presented at American Headache Society Meeting -

Technorati Tags: ,


Post a Comment

Google Analytics Alternative